SODIUM CHLORIDE SOLUTION 0.9%, mRNA-1345 clinical trials

A Phase 2, Randomized, Observer-Blind, Placebo-Controlled, Dose-Escalation Study to Evaluate the Reactogenicity, Safety, and Immunogenicity of mRNA-1345, an mRNA Vaccine Targeting Respiratory Syncytial Virus, in Pregnant Women, and Safety, and Immunogenicity in Infants Born to Vaccinated Mothers.

This study is testing a new vaccine for pregnant women to protect their babies from RSV, a common chest infection. We're looking at how safe the vaccine is, its side effects, and how well it helps the mother and baby fight off RSV.